QSP Summit

April 25-26, 2019

Le Meridien Boston Cambridge | 20 Sidney Street, Cambridge, MA

Register Now

About the Event

featured image

The Quantitative Systems Pharmacology (QSP) Summit is the premier, free conference dedicated to fostering an active community of industry and academic participants interested in topics relevant to QSP. In its third year, the QSP Summit is a two-day event featuring talks from key industry and academic researchers, a poster session with awards, and networking time with peers. 

The QSP Summit began as a one-day event dubbed QSP Day, and due to participant feedback the event is evolving into a two-day conference for the first time in 2019. 

Call for Abstracts

Abstract submission is open to all undergraduate, graduate, postdoctural, industry (biotechs and pharma) faculty and staff in any computational biology field, including: quantitative biology, bioinformatics, applied mathematics, biochemistry, biophysics, biomedical engineering, electrical engineering, and chemical engineering.

Three abstract authors will be invited to give a 15-minute presentation during the conference. In addition, cash prizes will be awarded to the top three student, graduate student, and postdoc posters, with first place receiving $500, second place receiving $350, and third place receiving $200. 

Submit an Abstract

speakers

 

The Agenda

09:00 AM 

Registration and breakfast

09:30 AM

John Burke, PhD
Co-Founder, President & CEO, Applied BioMath

Opening remarks

09:45 AM

Ted Rieger, PhD
Senior Principal Scientist, Pfizer

"Use of QSP modeling to advance pre-clinical and clinical drug candidates for the treatment of  non-alcoholic fatty liver disease"

10:30 AM

Werner Meier
CSO, Revitope Oncology

"Next-generation of T-cell redirecting antibodies"

View Abstract

11:15 AM

Break and poster viewing session

11:45 AM

Nathan Higginson-Scott, PhD
Director, Therapeutic Protein Technologies, Pandion Therapeutics

"Localized Immunomodulation for Treating Autoimmune Diseases"

12:30 PM

Lunch and poster viewing session

01:45 PM

Alina Starchenko, PhD
Postdoctoral Fellow, MIT

02:30 PM

Lightning talks by selected poster presenters

03:30 PM

Break and poster viewing session

04:00 PM

Joe Loscalzo, MD, PhD
Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School, Chairman of the Department of Medicine, and Physician-in-Chief at Brigham and Women's Hospital 

"Finding the right target with the right magic bullet: current challenges in drug development"

04:45 PM

Closing remarks and day one adjourns

 

09:00 AM

Registration and breakfast

09:30 AM

John Burke, PhD
Co-Founder, President & CEO, Applied BioMath 

Opening remarks

09:45 AM

Majid Vakilynejad, PhD
Senior Director, Quantitative Solutions, Takeda Pharmaceuticals

10:30 AM

Spyros Stamatelos, PhD
Group Leader, Quantitative Systems Pharmacology, Sanofi, US

"Implementation of mechanistic multiscale modeling to improve biological understanding and drive decision making in immuno-oncology"

View Abstract

11:00 AM

Break and poster viewing session 

11:45 AM

Matt Rizk, PhD
Director, Quantitative Pharmacology & Pharmacometrics, Merck 

"Let the question be your guide: case studies in integrating elements of Pharmacometrics and systems pharmacology"

12:30 PM

Closing remarks, poster awards, and lunch

02:00 PM Summit concludes

The Speakers

nathan

Nathan Higginson-Scott, PhD

Pandion Therapeutics

joe

Joseph Loscalzo, MD, PhD

Brigham and Women's Hospital

werner

Werner Meier

Revitope Oncology

View Presentation Information

ted

Ted Rieger, PhD

Pfizer

matt

Matthew Rizk, PhD

Merck

spyros

Spyros Stamatelos, PhD

Sanofi, US

View Presentation Information

alina

Alina Starchenko, PhD

Postdoctoral Fellow, MIT

majid

Majid Vakilynejad, PhD

Takeda Pharmaceuticals

The Venue

Le Meridien Boston Cambridge | 20 Sidney Street, Cambridge, MA 02139

" style="border:0" width="600">

Register

Submit an Abstract

Abstract Guidelines

  • Submit abstract by Friday, March 15, 2019 to be considered for a presentation at the conference.
  • Abstract limit is 500 words.
  • Abstract cannot be used for marketing purposes.
  • Abstract submission is open to all undergraduate, graduate, postdoctural, industry (biotechs and pharma) faculty and staff in any computational biology field, including: quantitative biology, bioinformatics, applied mathematics, biochemistry, biophysics, biomedical engineering, electrical engineering, and chemical engineering.
  • Please note the submitting author will receive all correspondence about the abstract. We suggest the submitting author details be the same as the presenting author details. 
  • We will review all submitted abstracts. Notification regarding abstract acceptance will be sent to the submitting author. 

Questions?

Contact Renee Fisher at rfisher@appliedbiomath.com.